These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22718505)

  • 1. New polymorphisms in human MEF2C gene as potential modifier of hypertrophic cardiomyopathy.
    Alonso-Montes C; Naves-Diaz M; Fernandez-Martin JL; Rodriguez-Reguero J; Moris C; Coto E; Cannata-Andia JB; Rodriguez I
    Mol Biol Rep; 2012 Sep; 39(9):8777-85. PubMed ID: 22718505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel genetic variant in the transcription factor Islet-1 exerts gain of function on myocyte enhancer factor 2C promoter activity.
    Friedrich FW; Dilanian G; Khattar P; Juhr D; Gueneau L; Charron P; Fressart V; Vilquin JT; Isnard R; Gouya L; Richard P; Hammoudi N; Komajda M; Bonne G; Eschenhagen T; Dubourg O; Villard E; Carrier L
    Eur J Heart Fail; 2013 Mar; 15(3):267-76. PubMed ID: 23152444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice.
    Xu J; Gong NL; Bodi I; Aronow BJ; Backx PH; Molkentin JD
    J Biol Chem; 2006 Apr; 281(14):9152-62. PubMed ID: 16469744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of early cardiac marker genes in circulating cells of patients with hypertrophic cardiomyopathy.
    Kontaraki JE; Parthenakis FI; Patrianakos AP; Karalis IK; Vardas PE
    Cardiovasc Pathol; 2007; 16(6):329-35. PubMed ID: 18005871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analysis of essential cardiac transcription factors in 256 patients with non-syndromic congenital heart defects.
    Kodo K; Nishizawa T; Furutani M; Arai S; Ishihara K; Oda M; Makino S; Fukuda K; Takahashi T; Matsuoka R; Nakanishi T; Yamagishi H
    Circ J; 2012; 76(7):1703-11. PubMed ID: 22498567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleotide sequence and variations of the bovine myocyte enhancer factor 2C (MEF2C) gene promoter in Bos taurus cattle.
    Juszczuk-Kubiak E; Flisikowski K; Wicińska K
    Mol Biol Rep; 2011 Feb; 38(2):1269-76. PubMed ID: 20585884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells.
    Maiti D; Xu Z; Duh EJ
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3640-8. PubMed ID: 18450586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity.
    Kang J; Gocke CB; Yu H
    BMC Biochem; 2006 Feb; 7():5. PubMed ID: 16478538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity.
    Zhu B; Gulick T
    Mol Cell Biol; 2004 Sep; 24(18):8264-75. PubMed ID: 15340086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare genetic variants in GATA transcription factors in patients with hypertrophic cardiomyopathy.
    Alonso-Montes C; Rodríguez-Reguero J; Martín M; Gómez J; Coto E; Naves-Díaz M; Morís C; Cannata-Andía JB; Rodríguez I
    J Investig Med; 2017 Jun; 65(5):926-934. PubMed ID: 28381408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy.
    Friedrich FW; Bausero P; Sun Y; Treszl A; Krämer E; Juhr D; Richard P; Wegscheider K; Schwartz K; Brito D; Arbustini E; Waldenström A; Isnard R; Komajda M; Eschenhagen T; Carrier L;
    Eur Heart J; 2009 Jul; 30(13):1648-55. PubMed ID: 19429631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of the myocyte enhancer factor 2A gene (MEF2A) in patients with left ventricular hypertrophy/hypertrophic cardiomyopathy.
    Coto E; Castro MG; Corao AI; Alonso-Montes C; Reguero JR; Morís C; Alvarez V
    Am J Med Genet A; 2009 Feb; 149A(2):286-9. PubMed ID: 19161138
    [No Abstract]   [Full Text] [Related]  

  • 13. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
    Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
    Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and prognostic evaluation of familial hypertrophic cardiomyopathy in two South African families with different cardiac beta myosin heavy chain gene mutations.
    Posen BM; Moolman JC; Corfield VA; Brink PA
    Br Heart J; 1995 Jul; 74(1):40-6. PubMed ID: 7662452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional regulatory regions of human transcription factor MEF2C.
    Janson CG; Chen Y; Li Y; Leifer D
    Brain Res Mol Brain Res; 2001 Dec; 97(1):70-82. PubMed ID: 11744164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The cSNPs analysis in whole extron-wide of PGC-1alpha gene in Chinese population and the domain MEF2C bioinformatics study].
    Lu WS; Yan XD; Liu HY; Huang Z; Tan XY; Huang Q; Yang C; Li Y; Yan L; Cheng H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):409-16. PubMed ID: 17680531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy.
    Flavigny J; Richard P; Isnard R; Carrier L; Charron P; Bonne G; Forissier JF; Desnos M; Dubourg O; Komajda M; Schwartz K; Hainque B
    J Mol Med (Berl); 1998 Mar; 76(3-4):208-14. PubMed ID: 9535554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resequencing the whole MYH7 gene (including the intronic, promoter, and 3' UTR sequences) in hypertrophic cardiomyopathy.
    Coto E; Reguero JR; Palacín M; Gómez J; Alonso B; Iglesias S; Martín M; Tavira B; Díaz-Molina B; Morales C; Morís C; Rodríguez-Lambert JL; Corao AI; Díaz M; Alvarez V
    J Mol Diagn; 2012 Sep; 14(5):518-24. PubMed ID: 22765922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.
    Richard P; Isnard R; Carrier L; Dubourg O; Donatien Y; Mathieu B; Bonne G; Gary F; Charron P; Hagege M; Komajda M; Schwartz K; Hainque B
    J Med Genet; 1999 Jul; 36(7):542-5. PubMed ID: 10424815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of new polymorphisms in the bovine myocyte enhancer factor 2D (MEF2D) gene on the expression rates of the longissimus dorsi muscle.
    Juszczuk-Kubiak E; Starzyński RR; Sakowski T; Wicińska K; Flisikowski K
    Mol Biol Rep; 2012 Aug; 39(8):8387-93. PubMed ID: 22714905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.